Prosecution Insights
Last updated: May 29, 2026

Examiner: KETCHAM, KAREN A

Tech Center 1600 • Art Units: 1611 1614

This examiner grants 20% of resolved cases

Performance Statistics

19.6%
Allow Rate
-40.4% vs TC avg
107
Total Applications
+36.1%
Interview Lift
1217
Avg Prosecution Days
Based on 46 resolved cases, 2023–2026

Rejection Statute Breakdown

0.4%
§101 Eligibility
2.8%
§102 Novelty
84.4%
§103 Obviousness
2.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18070405 SEPARATING MEMBRANE FOR DENTAL SURGERIES AND METHOD FOR MANUFACTURING THE SAME Non-Final OA NAN YA PLASTICS CORPORATION
17549989 Stable Skin Care Emulsion and Methods of Using the Same Non-Final OA The Procter & Gamble Company
17989940 SELF-ASSEMBLED COMPLEX CONTAINING IRON ION Final Rejection Korea University Research and Business Foundation
17731816 COMPOSITIONS SUITABLE AS SETTERS Non-Final OA L'OREAL
17602866 FORMULATIONS FOR ENCAPSULATION AND BIOAVAILABILITY IMPROVEMENT OF BIOACTIVE COMPOUNDS BASED ON NATURAL PLANT BASED MATERIALS Non-Final OA TECHNION RESEARCH & DEVELOPMENT FOUNDATION LIMITED
17258525 A STABLE LIQUID AGROCHEMICAL FORMULATION Non-Final OA UPL LTD
17436104 Rhamnolipids as deposition aid Non-Final OA Evonik Operations GmbH
17630032 ANTIMICROBIAL COMPOSITIONS AND ARTICLES COMPRISING THE SAME Non-Final OA 3M INNOVATIVE PROPERTIES COMPANY
18276111 COMPOSITIONS AND METHODS FOR TARGETED ANTIFIBROTIC THERAPY IN CHRONIC PANCREATITIS Non-Final OA University of Virginia Patent Foundation
18735277 INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS Final Rejection Pinata Holdings Inc.
18705117 SHAMPOO IN SOLID FORM TO BE RECONSTITUTED IN AN AQUEOUS ENVIRONMENT Non-Final OA LES SOLUTIONS ZERO DECHET FILLGOOD INC.
17726176 ORGANIC-INORGANIC COMPOSITE POWDER AND COMPOSITION INCLUDING THE SAME Final Rejection AMOREPACIFIC CORPORATION
17278844 TRANSDERMAL THERAPEUTICS SYSTEM WITH BARRIER LAYER Non-Final OA LTS Lohmann Therapie-Systeme AG
18431369 METHOD AND COMPOSITIONS FOR THE CONTROL OF SOME PESTS Non-Final OA FUTURE-TENSE TECHNOL DEVEL & ENTREPRENEURSHIP LTD
18293750 DEXMEDETOMIDINE TRANSDERMAL COMPOSITION, TRANSDERMAL PATCH AND PREPARATION METHOD THEREFOR AND USE THEREOF Non-Final OA YICHANG HUMANWELL PHARMACEUTICAL CO., LTD.
17765665 HERBICIDE COMPOSITIONS Non-Final OA UPL EUROPE LTD
18551781 NUTRACEUTICAL COMPOSITION COMPRISING INULIN FOR TREATING AND PREVENTING OCULAR DISORDERS OR INTESTINAL MICROBIOTA IMBALANCE Non-Final OA OPHTALMIS
17782140 FORMULATIONS COMPRISING A MINERAL AND/OR A VITAMIN AND A POLYSACCHARIDE, COMPOSITIONS THEREOF AND USE THEREOF IN SUPPLEMENTING SAID MINERAL AND/OR VITAMIN Final Rejection PHARMANUTRA S.P.A
18257014 USE OF PSILOCYBIN IN CANCER TREATMENT Non-Final OA Silo Pharma, Inc.
18297535 COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION Final Rejection Xygenyx Inc.
18307253 TOPICAL FORMULATIONS Non-Final OA ProVEDA Corporation
17795294 Compositions and Methods for Treating Aging-Related Disorders Final Rejection AgeLess Sciences, Inc.
17741844 OIL POWDER FOUNDATION Non-Final OA Tombow Pencil Co., Ltd.
17770404 ENCAPSULATED CARBONYL IRON SALT COMPOSITIONS AND PROCESS THEREOF Final Rejection Vikrant SURYAVANSHI
17638871 REBAMIPIDE FOR USE IN PREVENTION AND TREATMENT OF CROHN'S DISEASE Non-Final OA SQUARE POWER LTD.
17264090 METHOD FOR PRODUCING PARTICLE, AND PARTICLE PRODUCED BY THE METHOD AND MEDICAMENT Non-Final OA SHIZUOKA PREFECTURAL UNIVERSITY CORPORATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month